No Data
Toho, upward revision on 25/2, operating profit 620 billion yen←55 billion yen.
Toho <9602> announced a revision of its financial estimates for the fiscal year ending February 2025. Operating revenue was revised upward from 280 billion yen to 297 billion yen, and operating profit from 55 billion yen to 62 billion yen. With major hits in the film business such as "Crazy Rich House," "Detective Conan: The Crimson Love Letter," "Kingdom: The General and His Return," "The Last Mile," and the unexpected success of the sequel "Haikyu!! The Huge Dumpsite Showdown" generating box office revenue exceeding 11.5 billion yen from the previous consolidated fiscal year.
PostPrime: Summary of financial results for the 1st quarter of the fiscal year ending May 2025 [Japanese GAAP] (unconsolidated)
PostPrime: Presentation of financial results for the 1st quarter of the fiscal year ending May 2025
TKP, Hio Den, Takashimaya, Toho (15th)
※The above calendar is only a schedule and may be subject to change due to company circumstances. ---------------------------------------October 15th (Tue) ＜135A＞ VRAIN ＜1401＞ mbs ＜1407＞ West HD ＜1418＞ Interlife ＜1430＞ 1st Co. ＜1434＞ JESCOHD ＜1887＞ Japan Land Development ＜198A＞
DELTA-P, Rena Science, and others.
<198A>Establishment of a post-main board subsidiary <4598> DELTA-PDFP-10917 and the initiation of case registration for the phase 1/2 clinical trial of VEN in the usa <4889> Renascience Japan Agency for Medical Research and Development (AMED) adoption of the Smart Bio Drug Discovery Research Support Project <7050> Acquisition and subsidiary of the advertising business of Frontier I handled by Cinebridge's stock.
PostPrime: Interim report
No Data
No Data